A Study Comparing the Effect of Albiglutide With Exenatide on Regional Brain Activity Related to Nausea in Healthy Subjects
Clinical trial NCT02802514 · TERMINATED
Trial details
- NCT number
- NCT02802514
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-20
- Primary completion
- 2017-08-10
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.